{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T04:56:26Z","timestamp":1781326586123,"version":"3.54.1"},"reference-count":41,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"American Legion Auxiliary Fellowship","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"name":"Center for Epigenetics Scholar program","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Despite current multimodal therapies for glioblastoma (GBM), its prognosis remains grim. Thus, a tremendous need exists to identify new genetic drivers that may serve as potential therapeutic targets in glioblastoma (GBM). We describe an in vivo overexpression screening strategy to identify drivers of glioblastoma where we have leveraged TCGA datasets to conduct a functional genomics screen of prioritized open reading frames (ORFs) that are overexpressed and\/or amplified in GBM. To interrogate these potential drivers within a more relevant physiological context, the screening was accomplished in vivo in an orthotopic patient-derived glioma stem-like cell (GSC) model. Among 5 positive \u201chits\u201d from the screen, Cellular Communication Network factor 4 (CCN4) was prioritized for further evaluation. Our functional analyses demonstrated that CCN4 overexpression drives tumor growth in multiple GBM models. Depletion of CCN4 reduced growth in vitro and in vivo and markedly decreased colony formation with the growth phenotype restored upon ectopic expression of CCN4. Structural functional analysis of CCN4 was also conducted. We believe that this screening strategy can serve as a platform for further identification and validation of drivers of GBM.<\/jats:p>","DOI":"10.3390\/ijms27125227","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T06:33:44Z","timestamp":1781073224000},"page":"5227","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["In Vivo ORF Overexpression Screening Identifies CCN4 as a Regulator of Glioblastoma Growth Validated Across Multiple Models"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7977-5591","authenticated-orcid":false,"given":"Pushan","family":"Dasgupta","sequence":"first","affiliation":[{"name":"Department of Genomic Medicine, UT MD Anderson Cancer Center, Houston, TX 77030, USA"},{"name":"MD Anderson UTHealth Houston Graduate School of Biomedical Sciences, Houston, TX 77030, USA"},{"name":"Division of Neuro-Oncology, Department of Neurology, Baylor College of Medicine, Houston, TX 77030, USA"},{"name":"Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77054, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"21","DOI":"10.21873\/anticanres.11285","article-title":"Advances in Experimental Targeted Therapy and Immunotherapy for Patients with Glioblastoma Multiforme","volume":"37","author":"Polivka","year":"2017","journal-title":"Anticancer Res."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"v1","DOI":"10.1093\/neuonc\/nos218","article-title":"CBTRUS statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2005\u20132009","volume":"14","author":"Dolecek","year":"2012","journal-title":"Neuro Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00401-007-0243-4","article-title":"The 2007 WHO classification of tumours of the central nervous system","volume":"114","author":"Louis","year":"2007","journal-title":"Acta Neuropathol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"iv1","DOI":"10.1093\/neuonc\/nou223","article-title":"CBTRUS statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2007\u20132011","volume":"16","author":"Ostrom","year":"2014","journal-title":"Neuro Oncol."},{"key":"ref_5","first-page":"2935","article-title":"New molecularly targeted therapies for glioblastoma multiforme","volume":"32","author":"Polivka","year":"2012","journal-title":"Anticancer Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1101\/gad.1596707","article-title":"Malignant astrocytic glioma: Genetics, biology, and paths to treatment","volume":"21","author":"Furnari","year":"2007","journal-title":"Genes Dev."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1093\/brain\/awm204","article-title":"Long-term survival with glioblastoma multiforme","volume":"130","author":"Krex","year":"2007","journal-title":"Brain J. Neurol."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"The Cancer Genome Atlas Research Network (2008). Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature, 455, 1061\u20131068. Erratum in Nature 2013, 494, 506.","DOI":"10.1038\/nature07385"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.cell.2013.09.034","article-title":"The Somatic Genomic Landscape of Glioblastoma","volume":"155","author":"Brennan","year":"2013","journal-title":"Cell"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ccr.2013.08.001","article-title":"Mesenchymal differentiation mediated by NF-\u03baB promotes radiation resistance in glioblastoma","volume":"3","author":"Bhat","year":"2013","journal-title":"Cancer Cell"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1186\/s12967-024-05364-8","article-title":"An overview of CCN4 (WISP1) role in human diseases","volume":"22","author":"Singh","year":"2024","journal-title":"J. Transl. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.3892\/ijo.2017.4119","article-title":"Identification of WISP1 as a novel oncogene in glioblastoma","volume":"51","author":"Jing","year":"2017","journal-title":"Int. J. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1038\/s41467-020-16827-z","article-title":"Dual Role of WISP1 in maintaining glioma stem cells and tumor-supportive macrophages in glioblastoma","volume":"11","author":"Tao","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3171\/2016.9.JNS16278","article-title":"Ionizing radiation augments glioma tropism of mesenchymal stem cells","volume":"128","author":"Thomas","year":"2017","journal-title":"J. Neurosurg."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1126\/science.1241328","article-title":"Targeted therapy resistance mediated by dynamic regulation of extrachromosomal mutant EGFR DNA","volume":"343","author":"Nathanson","year":"2014","journal-title":"Science"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gpb.2020.10.005","article-title":"Chinese Glioma Genome Atlas (CGGA): A Comprehensive Resource with Functional Genomic Data from Chinese Glioma Patients","volume":"19","author":"Zhao","year":"2021","journal-title":"Genom. Proteom. Bioinform."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"18527","DOI":"10.1038\/s41598-022-23186-w","article-title":"Prodigiosin inhibits the proliferation of glioblastoma by regulating the KIAA1524\/PP2A signaling pathway","volume":"12","author":"Zhao","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/s41419-023-05959-x","article-title":"MGCG regulates glioblastoma tumorigenicity via hnRNPK\/ATG2A and promotes autophagy","volume":"14","author":"Chu","year":"2023","journal-title":"Cell Death Dis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1073929","DOI":"10.3389\/fphar.2023.1073929","article-title":"UBA1 inhibition contributes radiosensitization of glioblastoma cells via blocking DNA damage repair","volume":"14","author":"Wu","year":"2023","journal-title":"Front. Pharmacol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.2147\/CMAR.S133915","article-title":"The role of CCN4\/WISP-1 in the cancerous phenotype","volume":"10","author":"Nivison","year":"2018","journal-title":"Cancer Manag. Res."},{"key":"ref_21","first-page":"2","article-title":"Prostate stem cell antigen (PSCA) expression in human prostate cancer tissues and its potential role in prostate carcinogenesis and progression of prostate cancer","volume":"10","author":"Zhigang","year":"2004","journal-title":"World J. Surg. Oncol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"145","DOI":"10.18632\/oncotarget.27880","article-title":"High mRNA expression of LY6 gene family is associated with overall survival outcome in pancreatic ductal adenocarcinoma","volume":"12","author":"Russ","year":"2021","journal-title":"Oncotarget"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1093\/carcin\/bgab103","article-title":"CHRAC1 promotes human lung cancer growth through regulating YAP transcriptional activity","volume":"43","author":"Wang","year":"2022","journal-title":"Carcinogenesis"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"18219","DOI":"10.18632\/oncotarget.7788","article-title":"The role and potential mechanisms of LncRNA-TATDN1 on metastasis and invasion of non-small cell lung cancer","volume":"7","author":"Niu","year":"2016","journal-title":"Oncotarget"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"3486","DOI":"10.1111\/cas.14187","article-title":"Tyrosine kinase Eph receptor A6 sensitizes glioma-initiating cells towards bone morphogenetic protein-induced apoptosis","volume":"110","author":"Raja","year":"2019","journal-title":"Cancer Sci."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"63678","DOI":"10.7554\/eLife.63678","article-title":"EGFR transactivates RON to drive oncogenic crosstalk","volume":"10","author":"Green","year":"2021","journal-title":"eLife"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1038\/nn.4620","article-title":"AAV-mediated direct in vivo CRISPR screen identifies functional suppressors in glioblastoma","volume":"20","author":"Chow","year":"2017","journal-title":"Nat. Neurosci."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1093\/neuonc\/nos246","article-title":"Integrative functional genomics identifies RINT1 as a novel GBM oncogene","volume":"14","author":"Quayle","year":"2012","journal-title":"Neuro Oncol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.1158\/2159-8290.CD-20-1437","article-title":"Medium-Chain Acyl-CoA Dehydrogenase Protects Mitochondria from Lipid Peroxidation in Glioblastoma","volume":"11","author":"Puca","year":"2021","journal-title":"Cancer Discov."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s13059-020-02127-8","article-title":"Correction to: PiggyBac mutagenesis and exome sequencing identify genetic driver landscapes and potential therapeutic targets of EGFR-mutant gliomas","volume":"21","author":"Noorani","year":"2020","journal-title":"Genome Biol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/neuonc\/noac158","article-title":"Novel cancer gene discovery using a forward genetic screen in RCAS-PDGFB-driven gliomas","volume":"25","author":"Weishaupt","year":"2023","journal-title":"Neuro Oncol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.celrep.2019.03.047","article-title":"Genome-Wide CRISPR-Cas9 Screens Expose Genetic Vulnerabilities and Mechanisms of Temozolomide Sensitivity in Glioblastoma Stem Cells","volume":"16","author":"MacLeod","year":"2019","journal-title":"Cell Rep."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1186\/s12967-025-06261-4","article-title":"Large-scale CRISPRi screens link metabolic stress to glioblastoma chemoresistance","volume":"23","author":"Li","year":"2025","journal-title":"J. Transl. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"36228","DOI":"10.1038\/s41598-025-20183-7","article-title":"CRISPR screen reveals SOX2 as a critical regulator of CD133 and cellular stress response in glioblastoma","volume":"15","author":"Savage","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.cell.2014.09.029","article-title":"Genome-Scale CRISPR-Mediated Control of Gene Repression and Activation","volume":"23","author":"Gilbert","year":"2014","journal-title":"Cell"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Chen, L., Stuart, L., Ohsumi, T.K., Burgess, S., Varshney, G.K., Dastur, A., Borowsky, M., Benes, C., Lacy-Hulbert, A., and Schmidt, E.V. (2013). Transposon activation mutagenesis as a screening tool for identifying resistance to cancer therapeutics. BMC Cancer, 13.","DOI":"10.1186\/1471-2407-13-93"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3892\/ol.2014.2684","article-title":"Optimization of lentiviral vector production using polyethylenimine-mediated transfection","volume":"1","author":"Tang","year":"2015","journal-title":"Oncol. Lett."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.1158\/0008-5472.CAN-04-1874","article-title":"Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas","volume":"65","author":"Nakamizo","year":"2005","journal-title":"Cancer Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"326","DOI":"10.3171\/jns.2000.92.2.0326","article-title":"An implantable guide-screw system for brain tumor studies in small animals","volume":"92","author":"Lal","year":"2000","journal-title":"J. Neurosurg."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"102736","DOI":"10.1016\/j.ebiom.2020.102736","article-title":"Radiation-induced extracellular vesicle (EV) release of miR-603 promotes IGF1-mediated stem cell state in glioblastomas","volume":"55","author":"Ramakrishnan","year":"2020","journal-title":"eBioMedicine"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1126\/scitranslmed.aaf6853","article-title":"Origin of the U87MG glioma cell line: Good news and bad news","volume":"8","author":"Allen","year":"2016","journal-title":"Sci. Transl. Med."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/12\/5227\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T04:12:50Z","timestamp":1781323970000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/12\/5227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,9]]},"references-count":41,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["ijms27125227"],"URL":"https:\/\/doi.org\/10.3390\/ijms27125227","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,9]]}}}